to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Having a balanced and knowledgeable board of directors is crucial for new healthcare businesses. Here's advice on forming a board of directors.
When we think about the startup life we're often occupied with visions of long days and late nights in the office and the all consuming passion that overtakes a life as someone takes a vision and turns it into reality. An entrepreneur certainly has many things that can easily engulf his or her life as they balance product creation, customer development, hiring, sales and financing, to name but a few. But what about the other side of the life equation? Entrepreneurs have families, friends, spouses, and partners who play an important role.
Social media helps healthcare business leaders stay in touch with peers and the industry. Read one former hospital CEO's take.
Data will drive many of the sweeping changes coming with the Affordable Care Act to the U.S. healthcare system. At the StrataRx conference in Boston this week, innovators in “big data” for healthcare assessed its role in bringing advances in personalized and predictive medicine, major cost savings and research that leads to new technologies.
A new biomedical endowment at Duke University will support a program that has already launched new healthcare businesses. Read more to find out about Duke’s successes in commercializing medical technology.
Biotech companies will no longer be able to use wet laboratory space at Cincinnati incubator BioStart in September. However, the organization will continue to offer other services, such as market research, business model assistance and team-building support.
Are bioresorbable stents from one company better than another? Arterial Remodeling Technologies thinks so. The company boasts that its stents offer faster and smoother bioresorption and crack-free expansion.
At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.